Microscopic view inside mouse model of pancreatic cancer tumor using intravital imaging at Garvan’s ACRF Incite Centre. The colors indicate different components: red for blood vessels, green for tumor cells and purple for collagen, the connective tissue making therapy penetration challenging. Credit: Garvan Institute A molecule called nidogen-2 may be a key driver of pancreatic cancer progression and metastasis, offering a promising new treatment approach for this aggressive cancer, according to a Garvan Institute study. Researchers at the Garvan Institute of Medical Research have identified a potential new therapeutic target Read More